öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º¶¡ÏÈ·æ
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º423

ËùÊôԺУ£ºÕã½­Àí¹¤´óѧ
ËùÊôԺϵ£ºÉúÃü¿ÆѧѧԺ
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúÎïѧ
Ñо¿ÁìÓò£º Ö×ÁöѪÇåÖÐlncRNAµÄ±í´ïºÍ»úÀíÑо¿
Ñо¿ÁìÓò£º Ö×ÁöѪÇåÖÐlncRNAµÄ±í´ïºÍ»úÀíÑо¿ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
ͨѶµØÖ·£ºº¼ÖÝÏÂɳ2ºÅ´ó½ÖÕã½­Àí¹¤´óѧÉúÃü¿ÆѧѧԺ


¸öÈ˼òÊö :
¶¡ÏÈ·æ,½ÌÊÚ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£ Õã½­Àí¹¤´óѧÉúÃü¿ÆѧѧԺÉúÎï¿ÆѧʵÑéÖÐÐÄÖ÷ÈΣ¬Õã½­Ê¡ÉúÎï¿Æѧʾ·¶ÖÐÐÄÖ÷ÈΣ¬ÏȺóÈÎÖ°ÓÚ½­ÄÏ´óѧºÍÕã½­Àí¹¤´óѧ¡£Õ㽭ʡת»¯Ò½Ñ§Ñ§»áÀíÊ£¬Õ㽭ʡϸ°ûÉúÎïѧѧ»áÀíÊ£¬Õã½­Ê¡¿Æ¼¼´´ÐÂÍŶÓ×ÓÏîÄ¿¸ºÔðÈË£¬³¤ÆÚ´ÓÊÂDNA¼°RNAÑо¿µÄ¼¼Êõ¿ª·¢¹¤×÷£¬¿ªÕ¹Ö×ÁöÏà¹Ø±£ÊطDZàÂëRNAµÄɸѡÓ빦Äܼø¶¨¡£½¨Á¢ÁË΢Á¿ÑªÇåÌØÒìµÄmiRNA·ÖÀë´¿»¯¼¼Êõ£»ÀûÓøßͨÁ¿Ó«¹â¶¨Á¿PCR£¬ÏµÍ³·¢ÏÖ²¢ÑéÖ¤Ö×ÁöÏà¹ØµÄѪÇåmicroRNA£»²¢½øÒ»²½¾ÍÕâЩmiRNAÔÚÖ×Áö·¢ÉúÖеÄÉúÎïѧ¹¦ÄÜÕ¹¿ªÁËһЩÑо¿£¬ÔÚÖ×ÁöÔçÆÚ±êÖ¾ÎïµÄ·¢ÏÖºÍÓ¦Óá¢ÒÔ¼°Ö×ÁöѪÇåmiRNAµÄÉúÎïѧ¹¦Äܵȷ½Ãæ»ñµÃһЩ³É¹û£¬²¢ÓпÉÄܶÔÖ×ÁöµÄÔçÆÚÕï¶ÏÌṩһÖÖÐÂÐ͵ÄÁÙ´²Õï¶Ï¼¼Êõ£¬ÕâЩÑо¿³É¹û»ñ2015ÄêÕã½­Ê¡×ÔÈ»¿Æѧ½±ÈýµÈ½±¡£2008ºÍ2009Ä꣬Á½´ÎÇ°ÍùÃÀ¹úÐÝ˹¶Ù´óѧºÍLC Science¹«Ë¾¿ªÕ¹»ùÒòоƬÏà¹Ø¿ÎÌâÑо¿¹¤×÷£¬2015ÄêÔÚÃÀ¹úÃÜÎ÷Î÷±È´óѧ¿ªÕ¹LncRNAÓëÖ×ÁöµÄÑо¿¡£Ö÷³ÖºÍ²Î¼Ó¹ú¼Ò863ÏîÄ¿£¬Õã½­Ê¡×ÔÈ»¿Æѧ»ù½ð£¬Õã½­Ê¡¿Æ¼¼ÌüÖØ´óÏîÄ¿µÈ×ÝÏòÏîÄ¿10ÓàÏÖ÷³ÖºáÏòÏî6Ï·¢±íÂÛÎÄ50Óàƪ£¬SCI 30Óàƪ£¬½ü5ÄêgoogleËûÒý500¶à´Î£¬µ¥ÆªÂÛÎÄËûÒý£¨google£©200¶à´Î£¬ÉêÇëרÀû10ÓàÏÊÚȨרÀû8Ïî¡£

¿ÆÑй¤×÷ :
1) P Koirala , J Huang,T Ho, Fwu,X Ding*, Yin-Yuan Mo, LncRNA AK023948 is a positive regulator of AKT,Nature communication

1) P Koirala , J Huang,T Ho, Fwu,X Ding*, Yin-Yuan Mo, LncRNA AK023948 is a positive regulator of AKT,Nature communication£¬2016.12.28£¬8£¨14422£©IF 11.32

2) B chen , J Liu, T Ho,Y Mo ,X Ding*, ERK-mediated NF-¦ªb activation through ASIC1 in response to acidosis£¬Oncogenesis£¬2016.11.03£¬5£¨e279£©IF 5.021

3) J Huang, A Zhang, T Ho, Z Zhang, N Zhou,X Ding, X Zhang, Min Xu£¬and Y Mo,*Linc-RoR promotes c-Myc expression through hnRNP£¬I and AUF1£¬Nucleic Acids Research, 2015£¬12IF 9.112

4) H Liu, J Li, P Koirala,X Ding,B Chen, Y Wang, Z Wang, C Wang, X, Y Mo Long non-coding RNAs as prognostic markers in human breast cancer£¬Oncotarget£¬2016,03IF 6.359

5) X Meng, Y Li,H Tang,W Mao, H Yang,X Wang,X Ding*, Sh Xie, Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer,Amino Acids, 2016,48(2), 487-497

6)T Ji, Z Zheng, F Wang, L Xu, L Li, Q Cheng, J Guo,X Ding*, Differential microRNA expression by deep sequencing in the sera of the ovarian cancer patients.Asian Pacific journal of cancer prevention£¬2014£¬15: 1739-1743

7) S Zhang, C Zhu£¬L Zhu, H Liu, S Liu, N Zhao, J Wu, X Huang, Y Zhang, J Jin, T Ji,X Ding*, Oncogenicity of the Transcription Factor Sox8 in Hepatocellular Carcinoma, Med Oncol (2014) 31(918): 3-6

8£©ÃÏÀö£¬¼Íæ㬶¡ÏÈ·æ*£¬²ÉÓÃË«Ó«¹âËØø±¨¸æ·¨ÑéÖ¤ÈéÏÙ°©ÖÐmiR-155°Ð±ê. ÖйúÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ±¨£¬2013, 2:29(2):189-195

9) F Yi£¬F Yang£¬X Liu£¬H Chen, T Ji£¬L Jiang£¬X Wang, Z Yang£¬L Zhang£¬X Ding£¬* Z Liang* and Q Du*£¬RNA-seq identified a super-long intergenic transcript functioning in adipogenesis,2013, RNA Biology £¬10:6, 1¨C12

10) H Yang £¬Y Zheng £¬T Ji £¬X Ding£¬C Zhu £¬ X Fei Yu£¬Z Ling£¬Overexpression of ILK1 in breast cancer associates with poor prognosis£¬2013£¬Tumor Biol.£¬(2013) 34:3933¨C3938

11£©Yang F, Yi F, Zheng Z, Ling Z, Ding J, Guo J, Mao W, Wang X,Ding X£¬Liang Z, and Du Q(2012),Characterization of a carcinogenesis-associated long non-coding RNA,RNA Biology, 9(1): 110 ¨C 116 IF 5.59

12£©Ding X, Ding J, Ning J, Yi F, Zhao D, Zheng J, Liang Z, Hu Z, Du Q£¨2012£©Circulating microRNA as a potential biomarker for liver injury,Molecular Medicine Reports ,5: 1428-1432

13) Wang P, Guo Y, Cheng J, Dong Q,Ding X, Guo J, Jiang Y£¨2012£©Application of multiplex reverse transcription-ligase detection reaction-polymerase chain reaction (MRLP) mediated universal DNA microarray for detecting potato field samples. European Journal of Plant Pathology, 132(2): 217-227.

14£©Cheng Q, Zhang X,Ding X£¬Clinical Study on Acute Pancreatitis in Pregnancy in 26 Cases£¬Gastroenterology Research and Practice£¬ 2012

15) ÂíÇÙÇÙ£¬ÑϹúȨ£¬¹ù½­·å£¬¶¡ÏÈ·æ*(2012)£¬Ó°ÏìR NAоƬ̽ÕëÔÓ½»Ð§ÂʵÄÒòËØ·ÖÎö£¬Õã½­Àí¹¤´óѧѧ±¨£¬ 29£¨4£©£º590-595

16£© Li Y, Jiang Z, Xu L, Guo J andDing X* (2011) Stability Analysis of Liver Cancer Related MicroRNAs in Serum.Acta Biochimica et Biophysica Sinica, 43(1) :69-78.

17) Huang H, Wei Z, Huang Y, Zhao D. Zheng L, Cai, T, Wu N£¬Wang W,Ding X£¬Du,Q , Li Z, Liang Z (2011) An efficient and high-throughput electroporation microchip applicable for siRNA delivery. Lab on a Chip, 11(1):163-72 6.26

18)½ðÓ×·¼£¬Ðì¸ùÃ÷£¬ÀîÑÞ£¬ÃÏÀö£¬ ½ªÓÀºñ£¬¹ù½­·å£¬¶¡ÏÈ·æ*(2011)¶¨Á¿PCR¼ì²âmicroRNA±í´ïµÄÊý¾Ý¹éÒ»»¯Ð¼¼Êõ. ÉúÎﻯѧÓëÉúÎïÎïÀí½øÕ¹.38(5): 473-481ͨѶ×÷Õß IF 1.023

19) Wang P, Guo Y, Cheng J, Dong Q,Ding X,Guo J, Jiang Y£¨2011£© Development of multiplex reverse transcription- ligase detection reaction -polymerase chain reaction (MRLP) mediated universal DNA microarray for diagnostic platform. Biosensors and Bioelectronics, 26(8): 3719-3724. if 5.602

20£© Jiang Y, Guo Y, Wang P, Dong Q, Opriessnig T, Chen J, Xu H,Ding X, Guo J. A novel diagnostic platform based on multiplex ligase detection¨CPCR and microarray for swine viruses. Journal of Virological Method, 2011, 178: 171-178

21) Wang F, Zheng Z, Guo J andDing X* (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor.Gynecologic Oncology, 119(3): 586-593.

22) Jiang Y, Shang H, Xu H,Ding X, Zhao L, Fang L, Chen W.(2010)Detection and genotyping of porcine circovirus in naturally infected pigs by oligo-microarray. Res Vet Sci. 89(1): 133-9.

23)ÕÔµÂÒ¢£¬¶ÅȨ£¬¹ù½­·å£¬¶¡ÏÈ·æ* (2010)Ѫ½¬microRNAÌáÈ¡¼¼ÊõµÄÓÅ»¯, Õã½­Àí¹¤´óѧѧ±¨, 27(4):595-599

24£©Wang X, Zhou S,Ding X, Zhu G, Guo J. Effect of triazophos, fipronil and their mixture on miRNA expression in adult zebrafish, Journal of Environmental Science and Health, Part B, 2010, 45(7): 648-657

ÊÚȨרÀû£º

1£©¶¡Ïȷ棬¹ù½­·å£¬Ðì¸ùÃ÷£¬Íõ·ï¾ü£»Ò»ÖÖÉúÎïÑù±¾ÖÐmiRNA¾ø¶Ô±í´ïÁ¿µÄ¼ì²â·½·¨ ,2011,11,09£¬Öйú£¬ZL 2008 1 **.5

2£©¶¡ÏÈ·æ,¹ù½­·å£¬ÀîÑÞ£¬ÐìÁ¢¼á£¬Ò¦»¢£¬ÂÀ¼Ñá°£¬Öìºãâù£»microRNAÉúÎï±êÖ¾Îï¼°ÆäÓÃ;£¬2012,12,12£¬Öйú£¬ZL 2010 1 **.9

3£©¶¡ÏÈ·æ,¹ù½­·å£¬ÀîÑÞ£¬ÐìÁ¢¼á£¬Ò¦»¢£»Ò»ÖÖ´ÓÈËѪÇå/Ѫ½¬Ñù±¾ÖзÖÀëRNA·½·¨¼°ÆäPCRÑéÖ¤·¨£¬2013£¬,0,14£¬Öйú£¬ZL 2010 1 **.6
½üÎåÄê½Ìѧ³É¹û

³É¹ûÏîÄ¿Ãû³Æ

ÅÅÃû

ʱ¼ä

2013ÄêÌôÕ½±­¹ú¼Ò¶þµÈ½±£¨ÍÅÖÐÑ룩£¬¹ú¼Ò¼¶µ¥Ïî½±

1/2

2013.10

2013ÄêÕã½­Ê¡ÌôÕ½±­Ò»µÈ½±£¨Ê¡²¿¼¶µ¥Ïî½±£©

1/2

2013.05

2012У°ÙƪÓÅÐãÂÛÎÄÖ¸µ¼½ÌʦÌü¾Ö¼¶µ¥Ïî½±

1

2012£¬09

µØ·½ÔºÐ£ÉúÎïÀàöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¡°Ñ§ÍÅÖÆ¡±ÅàÑøģʽ̽Ë÷Óëʵ¼ù¡·±»ÆÀΪ2012ÄêУ½Ìѧ³É¹ûÒ»µÈ½±

5/14

2012,09

orrelation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor

Õã½­Ê¡×ÔÈ»¿ÆѧѧÊõ½± ÈýµÈ½±

1/4

2012,12

Õã½­Ê¡ÌôÕ½±­ÈýµÈ½±2Ïʡ²¿¼¶µ¥Ïî½±£©

1

2011£¬05